EODData

FRA, CN2: Catalyst Pharmaceuticals Inc

08 Sep 2025
LAST:

17.06

CHANGE:
 0.35
OPEN:
17.06
HIGH:
17.06
ASK:
0.00
VOLUME:
10
CHG(%):
2.06
PREV:
16.72
LOW:
17.06
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Sep 2517.0617.0617.0617.0610
05 Sep 2516.7216.7216.7216.7210
04 Sep 2516.9216.9216.9216.9210
03 Sep 2517.5117.5117.5117.5110
02 Sep 2517.7117.7117.7117.7110
01 Sep 2517.7117.7117.7117.7110
29 Aug 2517.4117.4117.4117.4110
28 Aug 2517.2617.2617.2617.2610
27 Aug 2517.0117.0117.0117.0110
26 Aug 2517.4817.4817.4817.4810

COMPANY PROFILE

Name:Catalyst Pharmaceuticals Inc
About:Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:355 Alhambra Circle, Coral Gables, FL, United States, 33134
Website:https://catalystpharma.com
ISIN:US14888U1016
LEI:5299004O0R5XXLA5H544

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:12.41
Price to Book:2.97
Price to Sales:3.84
EBITDA:281.25M
Shares:122.39M
Market Cap:2.088B

TECHNICAL INDICATORS

MA5:17.18
MA10:17.28
MA20:17.25
MA50:17.71
MA100:19.23
MA200:20.06
STO9:34.85
STO14:33.82
RSI14:47.60
WPR14:-66.18
MTM14:0.12
ROC14:0.01
ATR:0.28
Week High:17.71
Week Low:16.72
Month High:17.74
Month Low:16.64
Year High:23.86
Year Low:16.64
Volatility:45.57